Core Insights - TrueBlue has been recognized for its exceptional workplace culture and leadership in the staffing industry, receiving honors from Forbes, Staffing Industry Analysts (SIA), and HRO Today, highlighting its transformative impact on workforce solutions [1][2][5] Group 1: Workplace Culture - TrueBlue has been named to Forbes' 2025 America's Best Midsize Employers list, emphasizing its commitment to creating an environment where employees can thrive and innovate, which is crucial for attracting and retaining top talent [2] - The company aims to foster a culture that empowers employees to deliver value to clients, as stated by Board Chairman Jeff Sakaguchi [5] Group 2: Leadership Recognition - Taryn Owen, President and CEO of TrueBlue, has been included in SIA's 2025 Staffing 100 North America list for the ninth consecutive year, recognizing her influence in the staffing industry and her role in driving the company's growth [3] - TrueBlue's executive leadership team has five members honored in HRO Today Magazine's annual HR Superstars list, showcasing the company's expertise in workforce solutions and operational excellence [4] Group 3: Strategic Initiatives - Under Taryn Owen's leadership, TrueBlue has launched the next-generation JobStack app and expanded into the healthcare market through the acquisition of Healthcare Staffing Professionals, which are key strategic moves to enhance operational excellence and client outcomes [3]

Company Overview - TrueBlue (TBI) shares increased by 5.8% to close at $6.04, following a notable trading volume that exceeded typical levels, despite a 9.9% loss over the past four weeks [1] - The company is experiencing strong growth and profitability expansion due to effective strategic execution and rising customer demand [1] Earnings Expectations - TrueBlue is expected to report a quarterly loss of $0.23 per share, reflecting a year-over-year decline of 866.7% [1] - Revenue projections for TrueBlue stand at $361.12 million, which is a decrease of 10.4% compared to the same quarter last year [1] Earnings Estimate Revisions - The consensus EPS estimate for TrueBlue has been revised down by 2200% over the last 30 days, indicating a negative trend in earnings estimate revisions [3] - A negative trend in earnings estimate revisions typically does not lead to price appreciation, suggesting caution for future stock performance [3] Industry Comparison - TrueBlue operates within the Zacks Staffing Firms industry, which includes Resources Connection (RGP) [3] - Resources Connection's consensus EPS estimate for the upcoming report remains unchanged at -$0.10, representing a 158.8% decline from the previous year [4] - Resources Connection also holds a Zacks Rank of 3 (Hold), similar to TrueBlue [4]

Core Insights - TrueBlue has been recognized as one of the 2025 World's Most Ethical Companies® by Ethisphere, highlighting its commitment to ethical business practices, compliance, and governance [1][2][3] - The recognition reflects TrueBlue's dedication to integrity, transparency, and ethical conduct across its global operations, which is seen as a competitive differentiator [2][3] Company Overview - TrueBlue (NYSE: TBI) is a leading provider of specialized workforce solutions, offering services such as on-demand industrial staffing, recruitment process outsourcing, and healthcare staffing [6] - The company operates through various segments, including PeopleReady, PeopleScout, PeopleManagement, and Healthcare Staffing Professionals, catering to diverse industries [6] Recognition Details - In 2025, honorees were recognized across 19 countries and 44 industries, with TrueBlue outperforming a comparable index of global companies by 7.8 percentage points from January 2020 to January 2025 [2] - The assessment for the World's Most Ethical Companies is based on Ethisphere's proprietary Ethics Quotient®, which evaluates over 240 proof points related to ethics, compliance, governance, and social impact [4]

Core Insights - The expansion of the Amplifiers suite by PeopleScout addresses challenges in talent acquisition, focusing on engaging hard-to-reach talent and leveraging technology-driven hiring solutions [1] - PeopleScout's new consulting solutions aim to simplify complexities for employers, enhancing technology investments and employer branding [2] - The Amplifiers suite builds on over 30 years of expertise, providing diagnostics and strategic guidance to maximize ROI on technology investments and improve recruitment efficiency [3] Company Overview - PeopleScout, a subsidiary of TrueBlue, is a global leader in talent solutions, offering services such as Recruitment Process Outsourcing (RPO) and Managed Service Provider (MSP) solutions [5] - TrueBlue provides specialized workforce solutions across various segments, including industrial staffing and healthcare staffing [6] New Consulting Solutions - The new consulting solutions include Technology Diagnostic, which optimizes talent tech investments through AI-driven insights [8] - Organizational Culture and EVP Diagnostic focuses on strengthening company culture and enhancing employer branding through data-driven strategies [8] - Project Management services aim to minimize risk and enhance efficiency in executing internal projects and technology implementations [8]

Core Insights - Nexalin Technology, Inc. has received Institutional Review Board (IRB) approval for a clinical trial at the University of California, San Diego (UCSD) to evaluate its HALO™ Clarity devices for treating mild traumatic brain injury (mTBI) and post-traumatic stress disorder (PTSD) in military and civilian populations [1][2] Company Overview - Nexalin Technology specializes in developing innovative neurostimulation products aimed at addressing the global mental health crisis, utilizing non-invasive bioelectronic medical technology [4] - The company's proprietary Deep Intracranial Frequency Stimulation (DIFS™) technology offers a drug-free alternative for neurological and mental health conditions, minimizing side effects associated with traditional treatments [6] Clinical Trial Details - The initial shipment of HALO™ Clarity devices has been delivered to UCSD, with patient recruitment for the study commencing immediately [1][3] - An additional 40-50 HALO devices will be supplied as the study progresses, which will be integrated with Nexalin's app-controlled remote monitoring system for real-time tracking of patient progress [3][6] Technology and Advantages - The HALO™ Clarity device is designed for non-invasive deep-brain stimulation, providing a patient-centered treatment experience [3] - The combination of DIFS technology with an advanced virtual clinic model allows for seamless oversight of treatment adherence and progress [3][6] Future Aspirations - The initiation of patient recruitment is viewed as a significant milestone in validating the HALO Clarity device for TBI and PTSD treatment, with the potential to make non-invasive deep brain stimulation a viable solution for affected individuals [3]

Q4 2024 EARNINGS Forward-looking statements and non-GAAP financial measures This presentation contains forward-looking statements relating to our plans and expectations including, without limitation, statements regarding the future performance and operations of our business, expectations regarding stabilization in demand, and expected growth from our digital investments, all of which are subject to risks and uncertainties. Such statements are based on management's expectations and assumptions as of the date ...

TrueBlue, Inc. (NYSE:TBI) Q4 2024 Earnings Conference Call February 19, 2025 5:00 PM ET Company Participants Taryn Owen - CEO, President & Director Carl Schweihs - EVP & CFO Conference Call Participants Will Brunemann - Northcoast Research Mark Marcon - Baird Marc Riddick - Sidoti Operator Greetings, and welcome to the TrueBlue Fourth Quarter 2024 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded. At this time, I would like to remind everyone that today's call and slide ...

TrueBlue (TBI) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to earnings of $0.08 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 84.62%. A quarter ago, it was expected that this blue-collar temporary staffing company would post a loss of $0.23 per share when it actually produced a loss of $0.11, delivering a surprise of 52.17%.Over the last four quarter ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 29, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-14543 ____________________________________ TrueBlue, Inc. (Exact name of registrant as specified in its charter) ______________________________________ Washington 91-1287341 (S ...

Financial Highlights and Business Overview [Fourth Quarter & Full-Year 2024 Performance](index=1&type=section&id=Fourth%20Quarter%20%26%20Full-Year%202024%20Performance) TrueBlue reported significant revenue declines and widening net losses for Q4 and full-year 2024, driven by lower revenue and impairment charges | Metric | Q4 2024 | Q4 2023 | Change | Full-Year 2024 | Full-Year 2023 | Change | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | Revenue | $386M | $492M | -22% | $1.6B | $1.9B | -18% | | Net Loss | ($12M) | ($3M) | -300% | ($126M) | ($14M) | -800% | | Net Loss per Diluted Share | ($0.40) | ($0.08) | -400% | ($4.17) | ($0.45) | -827% | | Adjusted Net (Loss)/Income per Diluted Share | ($0.02) | $0.08 | -125% | ($0.46) | $0.28 | -264% | - On a comparable basis, Q4 revenue decreased by **16%** (13-week vs 13-week) and full-year revenue decreased by **17%** (52-week vs 52-week)[4](index=4&type=chunk) - Despite the revenue drop, Q4 Adjusted EBITDA increased to **$9 million** from **$5 million** in the prior year period, and SG&A expense improved by **18%** to **$107 million**[6](index=6&type=chunk) [Management Commentary & Strategic Priorities](index=1&type=section&id=Management%20Commentary%20%26%20Strategic%20Priorities) Management described 2024 as a transformative year, focusing on strategic priorities for future growth amidst challenging market conditions - CEO Taryn Owen noted that market conditions remain challenging, with customers awaiting improved market confidence before making significant workforce adjustments[3](index=3&type=chunk) - Key strategic priorities for long-term profitability include: - Advancing digital transformation with an enhanced user experience - Expanding into high-growth end-markets and high-value roles - Optimizing the business model to drive sales focus and accelerate growth[3](index=3&type=chunk) [2025 Outlook & Recent Developments](index=1&type=section&id=2025%20Outlook%20%26%20Recent%20Developments) TrueBlue started 2025 with the strategic acquisition of Healthcare Staffing Professionals, Inc. (HSP) to expand into the healthcare market, and is providing forward-looking guidance - On January 31, 2025, TrueBlue acquired Healthcare Staffing Professionals, Inc. (HSP), a provider of temporary and permanent healthcare staffing solutions, for **$42 million**[3](index=3&type=chunk)[6](index=6&type=chunk) - The company ended the period with **$23 million** in cash, **$8 million** in debt, and **$119 million** of borrowing availability[6](index=6&type=chunk) Consolidated Financial Statements [Consolidated Statements of Operations (Income Statement)](index=4&type=section&id=SUMMARY%20CONSOLIDATED%20STATEMENTS%20OF%20OPERATIONS) The company's revenue declined significantly in 2024, leading to a substantial increase in operating loss and a widened net loss, primarily due to a significant impairment charge | (in thousands) | Full-Year 2024 | Full-Year 2023 | | :--- | :--- | :--- | | Revenue from services | $1,567,393 | $1,906,243 | | Gross profit | $406,393 | $506,059 | | Goodwill and intangible asset impairment charge | $59,674 | $9,485 | | Loss from operations | ($92,775) | ($23,850) | | Net loss | ($125,748) | ($14,173) | | Diluted net loss per share | ($4.17) | ($0.45) | [Consolidated Balance Sheets](index=5&type=section&id=SUMMARY%20CONSOLIDATED%20BALANCE%20SHEETS) As of December 29, 2024, TrueBlue's total assets, liabilities, and shareholders' equity all decreased significantly, primarily due to reductions in cash, receivables, and goodwill | (in thousands) | Dec 29, 2024 | Dec 31, 2023 | | :--- | :--- | :--- | | Cash and cash equivalents | $22,536 | $61,885 | | Total current assets | $277,093 | $354,993 | | Goodwill and intangible assets, net | $30,406 | $94,639 | | **Total assets** | **$675,376** | **$899,383** | | Total current liabilities | $160,125 | $204,099 | | Long-term debt | $7,600 | $0 | | **Total liabilities** | **$360,017** | **$441,510** | | **Total shareholders' equity** | **$315,359** | **$457,873** | [Consolidated Statements of Cash Flows](index=6&type=section&id=CONSOLIDATED%20STATEMENTS%20OF%20CASH%20FLOWS) For the 52 weeks ended December 29, 2024, the company experienced a net cash outflow from operating activities, a sharp reversal from the prior year, primarily due to the significant net loss | (in thousands) | 52 weeks ended Dec 29, 2024 | 53 weeks ended Dec 31, 2023 | | :--- | :--- | :--- | | Net cash (used in) provided by operating activities | ($17,058) | $34,754 | | Net cash used in investing activities | ($2,453) | ($32,322) | | Net cash used in financing activities | ($17,087) | ($37,583) | | Net change in cash, cash equivalents, and restricted cash | ($38,206) | ($36,325) | Segment Performance [Segment Revenue](index=7&type=section&id=Segment%20Revenue) All three of TrueBlue's segments experienced revenue declines in 2024, with PeopleReady, PeopleScout, and PeopleManagement all reporting reduced top-line performance | Revenue (in thousands) | Full-Year 2024 | Full-Year 2023 | Change | | :--- | :--- | :--- | :--- | | PeopleReady | $868,549 | $1,096,318 | -20.8% | | PeopleScout | $156,643 | $229,334 | -31.7% | | PeopleManagement | $542,201 | $580,591 | -6.6% | | **Total company** | **$1,567,393** | **$1,906,243** | **-17.8%** | [Segment Profit](index=7&type=section&id=Segment%20Profit) Segment profit varied in 2024, with PeopleReady and PeopleScout declining significantly, while PeopleManagement's profit more than doubled, leading to an overall decrease in total segment profit | Segment Profit (in thousands) | Full-Year 2024 | Full-Year 2023 | Change | | :--- | :--- | :--- | :--- | | PeopleReady | $5,783 | $26,606 | -78.3% | | PeopleScout | $12,152 | $26,922 | -54.9% | | PeopleManagement | $15,119 | $6,963 | +117.1% | | **Total segment profit** | **$33,054** | **$60,491** | **-45.4%** | Non-GAAP Financial Measures & Reconciliations [Reconciliation of Net Loss to Adjusted Net Income (Loss)](index=9&type=section&id=Reconciliation%20of%20Net%20Loss%20to%20Adjusted%20Net%20Income%20(Loss)) After adjusting the GAAP net loss for items like goodwill impairment and tax effects, the company reported an adjusted net loss for fiscal year 2024, a reversal from adjusted net income in 2023 | (in thousands) | Full-Year 2024 | Full-Year 2023 | | :--- | :--- | :--- | | Net loss (GAAP) | ($125,748) | ($14,173) | | Goodwill and intangible asset impairment charge | $59,674 | $9,485 | | Tax effect of adjustments and deferred tax asset valuation allowance | $40,540 | ($4,920) | | **Adjusted net (loss) income (Non-GAAP)** | **($13,894)** | **$8,725** | [Reconciliation of Net Loss to EBITDA and Adjusted EBITDA](index=9&type=section&id=Reconciliation%20of%20Net%20Loss%20to%20EBITDA%20and%20Adjusted%20EBITDA) The company's Adjusted EBITDA for fiscal year 2024 significantly decreased from 2023, with the Adjusted EBITDA margin falling to **0.7%** from **1.5%** | (in thousands) | Full-Year 2024 | Full-Year 2023 | | :--- | :--- | :--- | | Net loss (GAAP) | ($125,748) | ($14,173) | | EBITDA (Non-GAAP) | ($63,214) | $1,971 | | **Adjusted EBITDA (Non-GAAP)** | **$11,167** | **$28,984** | [Reconciliation of SG&A to Adjusted SG&A](index=10&type=section&id=Reconciliation%20of%20SG%26A%20to%20Adjusted%20SG%26A) GAAP SG&A expenses decreased in 2024, and after adjustments, Adjusted SG&A remained flat as a percentage of revenue for both 2024 and 2023, indicating cost control in line with falling revenues | (in thousands) | Full-Year 2024 | Full-Year 2023 | | :--- | :--- | :--- | | SG&A expense (GAAP) | $410,870 | $494,603 | | **Adjusted SG&A expense (Non-GAAP)** | **$393,786** | **$478,958** | | Adjusted SG&A as % of revenue | 25.1% | 25.1% |